Valuation: M3, Inc.

Market Cap 1,180B 7.5B 6.59B 6.21B 5.66B 10.61B 719B 10.68B 73.82B 28.73B 367B 28.18B 27.57B P/E 2027 *
22.6x
P/E 2028 * 20.1x
Enterprise Value 1,039B 6.61B 5.8B 5.47B 4.99B 9.34B 633B 9.41B 65.05B 25.31B 323B 24.83B 24.29B EV / Sales 2027 *
2.67x
EV / Sales 2028 * 2.38x
Free-Float
61.47%
Yield 2027 *
1.32%
Yield 2028 * 1.46%
1 day+1.89%
3 months+21.17%
6 months-5.80%
Current year-24.69%
Current year 8.55
Extreme 8.552
14
1 year 8.55
Extreme 8.552
15.25
3 years 8.33
Extreme 8.33
17.84
5 years 8.33
Extreme 8.33
64.37
10 years 0
Extreme 0
102
Manager TitleAgeSince
President 61 28/09/2000
Investor Relations Contact 46 -
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 61 28/09/2000
Director/Board Member 53 31/05/2012
Director/Board Member 61 31/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.89%-.--% - - 7.5B
-0.41%+4.20%-32.83%+43.43% 501B
-0.80%-0.90%-41.12%+84.89% 296B
+0.58%-1.25%-28.67%+55.02% 142B
+5.03%+10.29%+463.98%+2,645.10% 116B
-0.27%+0.11%-28.43%+227.94% 105B
+4.02%-5.26%+29.34%+17.39% 92.84B
+1.83%+0.67%-37.77%+29.19% 86.91B
+3.11%+0.22%-26.22%+156.21% 83.78B
-0.34%-0.73%-41.16%+13.79% 32.36B
Average +1.46%+1.68%+28.57%+363.66% 161.73B
Weighted average by Cap. +0.68%+2.28%+9.50%+276.09%

Financials

2027 *2028 *
Net sales 389B 2.47B 2.17B 2.05B 1.87B 3.49B 237B 3.52B 24.32B 9.46B 121B 9.28B 9.08B 424B 2.7B 2.37B 2.23B 2.04B 3.82B 259B 3.84B 26.56B 10.34B 132B 10.14B 9.92B
Net income 51.7B 329M 289M 272M 248M 465M 31.49B 468M 3.24B 1.26B 16.09B 1.23B 1.21B 57.84B 368M 323M 305M 278M 520M 35.23B 524M 3.62B 1.41B 18B 1.38B 1.35B
Net Debt -140B -892M -783M -739M -673M -1.26B -85.45B -1.27B -8.78B -3.42B -43.66B -3.35B -3.28B -169B -1.07B -943M -889M -811M -1.52B -103B -1.53B -10.57B -4.11B -52.57B -4.03B -3.95B
Logo M3, Inc.
M3 Inc is a Japan-based company mainly engaged in the provision of services centering on the platform of healthcare. The Company has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is engaged in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.
Employees
17,010
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
1,767.50JPY
Average target price
1,990.00JPY
Spread / Average Target
+12.59%

Quarterly revenue - Rate of surprise